09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

4-CHLORO-o-PHENYLENEDIAMINE<br />

CAS No: 95-83-0<br />

I. PHYSICAL AND CHEMICAL PROPERTIES (From HSDB, 1994)<br />

Molecular weight 142.60<br />

Boiling point<br />

not available<br />

Melting point 76 °C (NCI, 1978)<br />

Vapor pressure<br />

not available<br />

Air concentration conversion 1 ppm = 5.83 mg/m 3<br />

II.<br />

HEALTH ASSESSMENT VALUES<br />

Unit Risk Factor: 4.6 E-6 (µg/m 3 ) -1<br />

Slope Factor: 1.6 E-2 (mg/kg-day) -1<br />

[Male rat urinary bladder tumor data (NCI, 1978), contained in Gold et al. (1990), expedited<br />

Proposition 65 methodology (Cal/EPA, 1992), cross-route extrapolation.]<br />

III.<br />

CARCINOGENIC EFFECTS<br />

Human Studies<br />

No studies on the potential carcinogenic effects of 4-chloro-o-phenylenediamine in humans are known<br />

to exist.<br />

Animal Studies<br />

Male and female Fischer 344 (F344) rats and B6C3F 1 mice were fed diets containing 4-chloro-ophenylenediamine<br />

(NCI, 1978). Dietary 4-chloro-o-phenylenediamine concentrations and treatment<br />

durations for rats and mice are listed in Table 1. Treatment group sizes were 50<br />

animals/sex/species/group, except for low-dose male rats, where a group size of 49 was used.<br />

At study termination, 84, 84 and 70% of male mice, and 72, 88 and 78% of female mice in the control,<br />

low-dose and high-dose groups, respectively, were still alive. Survival in treated rats was somewhat<br />

lower; 64, 80 and 56% of male rats and 72, 84 and 54% of female rats in the control, low-dose and<br />

high-dose groups, respectively, were still alive at study termination. Significantly increased treatmentrelated<br />

liver tumor (hepatocellular adenomas, carcinomas) incidences were noted in both male and<br />

female mice. These data are listed in Table 2. A significant dose-related trend was also noted in the<br />

increased incidence of urinary bladder carcinomas in male (transitional cell papillomas, carcinomas) and<br />

female (papillary or transitional cell carcinomas) rats (Table 2). Increases in the incidence of<br />

forestomach tumors also occurred in both male and female rats. The forestomach tumor increases were<br />

not statistically significant; however, these tumors are rare in F344 rats.<br />

201

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!